Stevens K E, Shiotsu G, Stein L
Department of Pharmacology, College of Medicine, University of California, Irvine 92717.
Brain Res. 1991 Apr 5;545(1-2):8-16. doi: 10.1016/0006-8993(91)91263-z.
Dependence on reinforcing chemicals is manifested when drug-seeking and drug-taking behaviors come to dominate the response repertoire. Clinical observations suggest that the craving and compulsive drug-seeking that characterize drug dependence are aroused by memories of the reinforcing drug experience. If so, a brain structure intimately associated with memory--the hippocampus--would be a plausible substrate for drug reinforcement effects. We report here that drug-naive rats rapidly learn to self-administer the opioid peptide dynorphin A in the CA3 region of hippocampus, and that this behavior is blocked by co-administration of the non-selective opiate antagonist naloxone. Subsequent studies demonstrated that coadministration of mu-, but not kappa- or delta-opioid antagonists also blocked self-administration behavior. We conclude that mu-receptors in the CA3 region of hippocampus may be important target sites for opioid dependence.
当寻求药物和服用药物的行为开始主导反应模式时,对强化化学物质的依赖就表现出来了。临床观察表明,药物依赖所特有的渴望和强迫性药物寻求是由强化药物体验的记忆所激发的。如果是这样,与记忆密切相关的脑结构——海马体——将是药物强化作用的一个合理基质。我们在此报告,未接触过药物的大鼠能迅速学会在海马体CA3区自我注射阿片肽强啡肽A,并且这种行为会被同时给予非选择性阿片拮抗剂纳洛酮所阻断。随后的研究表明,共同给予μ-阿片拮抗剂(而非κ-或δ-阿片拮抗剂)也会阻断自我给药行为。我们得出结论,海马体CA3区的μ-受体可能是阿片类药物依赖的重要靶点。